Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valproic Acid for HNSCC Chemoprevention
NCT02608736Phase 1Completed
- Sponsor
- Hospital de Amor
- Start
- Dec 2015
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial in head and neck squamous cell carcinoma (HNSCC) comparing Valproic Acid with Placebo (2 arms). Primary endpoint: Changes in protein or histone acetylation at 3 months. Started Dec 2015; status: completed.
02
Drugs
valproic acid
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT02608736.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02608736.